These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8535199

  • 1. Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia.
    Uozumi K, Hanada S, Ohno N, Ishitsuka K, Shimotakahara S, Otsuka M, Chyuman Y, Nakahara K, Takeshita T, Kuwazuru Y.
    Leuk Lymphoma; 1995 Jul; 18(3-4):317-23. PubMed ID: 8535199
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL).
    Uozumi K, Nakahara K, Takatsuka Y, Ohno N, Makino T, Utsunomiya A, Hanada S, Arima T.
    Leuk Lymphoma; 1998 Apr; 29(3-4):407-14. PubMed ID: 9684938
    [Abstract] [Full Text] [Related]

  • 3. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma.
    Matsushita K, Matsumoto T, Ohtsubo H, Fujiwara H, Imamura N, Hidaka S, Kukita T, Tei C, Matsumoto M, Arima N.
    Leuk Lymphoma; 1999 Dec; 36(1-2):67-75. PubMed ID: 10613451
    [Abstract] [Full Text] [Related]

  • 4. [ATL (adult T-cell leukemia/lymphoma)].
    Ichimaru M, Tsukazaki K, Ikeda S.
    Rinsho Ketsueki; 1989 Aug; 30(8):1208-11. PubMed ID: 2601035
    [Abstract] [Full Text] [Related]

  • 5. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
    Hermine O, Allard I, Lévy V, Arnulf B, Gessain A, Bazarbachi A, French ATL therapy group.
    Hematol J; 2002 Aug; 3(6):276-82. PubMed ID: 12522449
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.
    Tsukasaki K, Ikeda S, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Jubashi T, Yamada Y, Mine M.
    Leuk Res; 1993 Feb; 17(2):157-66. PubMed ID: 8429692
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia.
    Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ichimaru M, Tominaga S, Tsugane S, Minato K.
    J Clin Oncol; 1988 Jul; 6(7):1088-97. PubMed ID: 2899140
    [Abstract] [Full Text] [Related]

  • 11. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
    Kawano N, Yoshida S, Kuriyama T, Tahara Y, Yamashita K, Nagahiro Y, Kawano J, Koketsu H, Toyofuku A, Manabe T, Beppu K, Ono N, Himeji D, Yokota-Ikeda N, Inoue S, Ochiai H, Sonoda KH, Shimoda K, Ishikawa F, Ueda A.
    Intern Med; 2015 Jul; 54(12):1489-98. PubMed ID: 26073237
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL).
    Jabbour E, Koscielny S, Sebban C, Peslin N, Patte C, Gargi T, Biron P, Fermé C, Bourhis JH, Vantelon JM, Arnaud P, Ribrag V.
    Leukemia; 2006 May; 20(5):814-9. PubMed ID: 16511514
    [Abstract] [Full Text] [Related]

  • 15. Treatment for adult T-cell leukemia.
    Hanada S, Utsunomiya A, Suzuki S, Uozumi K, Makino T, Arima T.
    Cancer Chemother Pharmacol; 1997 May; 40 Suppl():S47-50. PubMed ID: 9272134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma.
    Nakashima J, Imaizumi Y, Taniguchi H, Ando K, Iwanaga M, Itonaga H, Sato S, Sawayama Y, Hata T, Yoshida S, Moriuchi Y, Miyazaki Y.
    Int J Hematol; 2018 Nov; 108(5):516-523. PubMed ID: 30032392
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.